PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Toxicol Pathol. Author manuscript; available in PMC 2007 March 19.
Published in final edited form as:
PMCID: PMC1828535
NIHMSID: NIHMS15879

Enhanced Histopathology of the Spleen

Abstract

The spleen is the largest secondary lymphoid organ, is considered the draining site for compounds that are administered intravenously, and is therefore considered an important organ to evaluate for treatment-related lesions. Due to the presence of B and T lymphocytes, the immunotoxic effects of xenobiotics or their metabolites on these cell populations may be reflected in the spleen. Therefore it is one of the recommended organs to evaluate for enhanced histopathology of the immune system. The two major functional zones of the spleen are the hematogenous red pulp and the lymphoid white pulp (periarteriolar sheaths, follicles and marginal zones). For enhanced histopathology, these splenic compartments should be evaluated separately for changes in size and cellularity, and descriptive rather than interpretive terminology should be used to characterize any changes (Haley et al., 2005). Moreover, germinal center development within the lymphoid follicles should be noted as increased or decreased.

Keywords: Spleen, red pulp, white pulp, PALS, marginal zone, follicles

Introduction

The spleen is considered the draining site for compounds that are administered intravenously (US FDA, 2001). The two major functional zones of the spleen are the hematogenous red pulp and the lymphoid white pulp. The white pulp, located around a central arteriole, is composed of the periarteriolar lymphoid sheath (PALS, T-cell area), the adjacent follicles (B-cell area), and marginal zone (B-cell area) (Figure 1). The marginal zone lies between the white and red pulp and the junction between the marginal zone and red pulp is not always distinct. In addition to lymphocytes, the marginal zone contains specific populations of macrophages. The splenic architecture is similar across species; however the marginal zone of the rat is comparatively prominent.

Figure 1
Normal spleen from a control rat is depicted in Figures 1a–c. In Figure 1a the arrowhead indicates the PALS region of the spleen surrounding the central artery. This is the darkest region of the white pulp due to the presence of predominately ...

According to the STP position paper: Best Practice Guideline for the Routine Pathology Evaluation of the Immune System (Haley et al., 2005), the separate compartments in each lymphoid organ should be evaluated separately and descriptive rather than interpretive terminology should be used to characterize changes within those compartments. Therefore, the PALS, lymphoid follicles, marginal zone, and red pulp should be evaluated separately for changes in size and cellularity. Germinal center development within the lymphoid follicles should be noted as increased or decreased. Typical cellular changes that can be observed after exposure to an immunomodulatory agent are an alteration in the size and density of the PALS and/or marginal zone, and a change in the number of follicles with germinal centers (Gopinath, 1996; Harleman, 2000; Kuper et al., 2000). Measures of follicle cellularity and germinal center development have been reported to be the most sensitive predictors for potential immunotoxicity whereas subtle changes in the red pulp are often difficult to detect (Germolec et al., 2004). See Cesta for more detailed information on the normal structure and function of the spleen (Cesta, 2006).

White Pulp

Decreased cellularity of the PALS region can occur after exposure to irradiation, viruses or drugs that can cause necrosis or apoptosis of the T cells (Figure 2). Athymic animals also have decreased cellularity in this T cell-rich region. There can also be specific decreased cellularity of the B cell-rich marginal zone, although this is a less frequent treatment-related effect but may be increasingly encountered with the development of novel immunomodulatory drugs (Haley, personal communication) (Figure 3). Such a change may be suggestive of deficits in T-independent humoral immune responses. Some chemicals, such as N,N-dimethyl-p-toluidine and AZT/Methadone HCL will cause an overall decrease in the cellularity and area of the white pulp (Figures 4 and and5).5). Increased cellularity of the PALS region may be seen with certain chemical treatments such as Citral and androstenedione (Figures 6 and and7)7) but there can also be increased cellularity of this region in early metastasis of thymic T-cell lymphomas, and other lymphomas and leukemias.

Figure 2
Splenic tissue from a 30-day-old Sprague Dawley rat treated with dexamethasone is depicted in Figures 2a–d. At low magnification (Figure 2a) the PALS region appears “moth-eaten” due to a moderate degree of scattered lymphocyte ...
Figure 3
Figures 3a–c are images of a spleen from a 90-day-old F344 rat treated with riddelline. There is diffuse and severe decreased cellularity of the B lymphocytes in the marginal zone (arrows in 3b and 3c). Higher magnification in Figure 3b shows ...
Figure 4
Figures 4a and 4b are low and high magnifications images of a spleen from a male F344 rat in a N,N-dimethyl-p-toluidine subchronic study. Figures 4c and 4d are low and high magnification images from an age- and sex-matched control rat with prominent marginal ...
Figure 5
This spleen is from a female B6C3F1 mouse that was treated with 800 mg/kg bodyweight of the antiviral drug azidothymidine (AZT) plus methadone HCL for 90 days. This treatment resulted in decreased cellularity of both the white pulp and red pulp. The capsular ...
Figure 6
The low and high magnification images of the spleen in Figures 6a and 6b are from a 90-day-old male B6C3F1 mouse treated with citral and an age-and sex-matched control from the same study is provided in Figures 6c and 6d for comparison. In this study, ...
Figure 7
This spleen is from a male B6C3F1 mouse in a subchronic androstenedione study. The diagnosis was a mild increase in lymphocyte cellularity and mild lymphocyte apoptosis based on an appropriate grading scheme for this study. Figure 7a shows the expansion ...

An acute immune response to antigens may result in increased cellularity in the B-cell areas and an increase in secondary follicles with prominent germinal centers. Immature B cells, or immunoblasts, will proliferate in response to antigenic stimuli. These cells are larger and paler-staining than the mature lymphocytes and have rounded, regular nuclear membranes. They will mature to immunoglobulin-producing plasma cells and migrate into the red pulp. F344 rats with mononuclear cell leukemia (MCL) may have an apparent increased cellularity in the marginal zone due to infiltration or sequestration of the large granular lymphocyte leukemic cells within this region. Marked increased in cellularity of the white pulp is sometimes difficult to distinguish from neoplasia. See Suttie for a comprehensive review of splenic lesions and discussion of borderline diagnoses of splenic neoplasia (Suttie, 2006).

Red Pulp

The red pulp should also be evaluated for changes in lymphocyte numbers. Reactive extramedullary hematopoiesis may be seen in conjunction with conditions that target the destruction of lymphocytes. This condition must be differentiated from the infiltration of the red pulp with large granular lymphocyte leukemic cells in F344 rats with MCL. It is also possible to identify decreased lymphocyte cellularity of the red pulp in those cases where systemic lymphocyte numbers are significantly decreased. Although the red pulp contains lymphocytes and macrophages, it is predominantly composed of red blood cells. For this reason there can be variation in splenic size and weight as well as histological variation in red pulp size and erythrocyte cellularity depending on the method of euthanasia and the efficacy of exsanguination at necropsy. However, variations in spleen weight due to methods of exsanguination are more likely to be encountered in dogs and monkeys, rather than rats. The available evidence suggests that splenic weight is a relatively insensitive indicator of immunotoxicity (Luster et al., 1992). In order to be toxicologically significant, the changes in spleen weight should be dose related and be confirmed with histopathological evaluation.

Aging Lesions

Increased cellularity in the B cell-rich follicles or marginal zones can be seen in aging rats and mice without any apparent increase in plasma cells. Enlarged spleens with decreased lymphocyte cellularity and increased myelopoiesis may be seen in aging rats, especially Sprague-Dawley rats, without an apparent etiology.

Additional Cells and Lesions

The presence, severity grade and location of plasma cells, apoptotic cells, tingible body macrophages, pigmented macrophages, granulocytes and hematopoietic cells should also be noted. Although granulomas, macrophage aggregates, fibrosis and necrosis are not strictly a component of enhanced histopathology, they should be noted during the evaluation. An example of a checklist for the changes to be noted in the spleen for enhanced histopathology is given in Table 1. This table is intended to be an example of a guideline that the pathologist can use during histological evaluation rather than a format for reporting lesions. The diagnoses listed in this table are descriptive rather than interpretive, consistent with the STP position paper: Best Practice Guideline for the Routine Pathology Evaluation of the Immune System (Haley et al., 2005).

TABLE 1
Spleen.

Footnotes

This research was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences.

References

  • Cesta MF. Normal structure, function, and histology of the spleen. Toxicol Pathol. 2006;34:455–465. [PubMed]
  • Germolec DR, Kashon M, Nyska A, Kuper CF, Portier C, Kommineni C, Johnson KA, Luster MI. The accuracy of extended histopathology to detect immunotoxic chemicals. Toxicol Sci. 2004;82:504–14. [PubMed]
  • Gopinath C. Pathology of toxic effects on the immune system. Inflamm Res. 1996;45(Suppl 2):S74–S8. [PubMed]
  • Haley P, Perry R, Ennulat D, Frame S, Johnson C, Lapointe JM, Nyska A, Snyder P, Walker D, Walter G. STP position paper: best practice guideline for the routine pathology evaluation of the immune system. Toxicol Pathol. 2005;33:404–7. [PubMed]
  • Harleman JH. Approaches to the identification and recording of findings in the lymphoreticular organs indicative for immunotoxicity in regulatory type toxicity studies. Toxicology. 2000;142:213–9. [PubMed]
  • Kuper CF, Harleman JH, Richter-Reichelm HB, Vos JG. Histopathologic approaches to detect changes indicative of immunotoxicity. Toxicol Pathol. 2000;28:454–66. [PubMed]
  • Luster MI, Portier C, Pait DG, White KL, Jr, Gennings C, Munson AE, Rosenthal GJ. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam Appl Toxicol. 1992;18:200–10. [PubMed]
  • Suttie AW. Histopathology of the spleen. Toxicol Pathol. 2006;34:466–503. [PubMed]
  • U.S. Food and Drug Administration (US FDA), Department of Health and Human Services, Center for Drug Evaluation and Research (CDER) Guidance for Industry Immunotoxicology Evaluation of Investigational New Drugs. 2001. [October 2002]. http://www.fda.gov/cder/guidance/index.html.